INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Effective Strategies To Minimize Product Loss During Fill Finish
Every drop of high-value biologic lost in fill finish is money left on the table. Learn practical strategies to protect your yield.
-
From Lipids To Launch: End-To-End Therapy Development
Explore integrated capabilities spanning lipid manufacturing, nanoparticle formulation, and more with support designed to move complex therapies from preclinical development through commercialization.
-
De-Risking A Novel Valve Component For Use With Standard Syringe Systems
A novel valve provides dual‑chamber functionality within standard syringes, keeping two liquid drugs separated until injection while reducing development risk through advanced modeling.
-
BioTitan Retention Device Overview
Learn about a retention device that provides robust fortification for single-use assemblies. Its 360-degree seal strengthens connections, reduces leak risks, and ensures process integrity for fluid transfer.
-
Reading Between The Lines: How To Evaluate Decontamination Cycle Time Claims8/19/2026
Comparing isolator decontamination cycle times requires evaluating key variables like aeration endpoints and load patterns to build accurate capacity models and avoid costly delays.
-
Decontamination Of Aseptic Pharmaceutical Isolators Using Vaporized And Aerosolized Hydrogen Peroxide8/26/2026
Aerosolized hydrogen peroxide decontamination cuts isolator cycle times from 70 to 15 minutes while drastically reducing biocide and overall energy usage.
-
5 Key Questions On Implementing Pharma 4.0 Solutions For Fill-Finish12/1/2025
Pharma 4.0™ leverages IoT, AI, and automation to enhance drug quality. Evaluate your fill-finish line readiness by considering five key questions on modularity, high-risk process automation, and data integration.
-
A Direct Path To Annex 1 Compliance With Blow/Fill/Seal Technologies9/13/2025
Learn how Blow/Fill/Seal technology supports contamination control, reduces operator risk, and meets sterility assurance requirements under dynamic conditions with advanced airflow and monitoring.
-
Maximize Your Drug Product Recovery With A Complete Fill Finish Solution5/29/2025
Discover how to maximize drug product recovery with an end-to-end fill-finish solution. Get excellent integrity assurance and exceptional lead times for your critical processes.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Used 12.26 sq meter (131.91 sq ft) BOC IMA freeze dryer, model LyoMax12, 316L stainless steel product contact surfaces, wth (12) total, (11) usable shelves, 914mm x 1219MM x 15mm thick shelves, 145mm shelf spacing, top down stoppering, rated to -60 c min temperature, slotted doors with unloading system, 17 sq meter external condensor, 345 kg ice capacity, (3) 30 hp Mycom refrigeration compressors, (2) EH250 Edwards vacuum pumps, SIP/CIP capable, Allen Bradley controls, 480 volt, serial# FD2889, built 1996.
-
Aseptic fill‑finish services support parenteral drug products with advanced formulation development, scalable vial and prefilled syringe manufacturing, and integrated quality and regulatory support.
-
Containment is a major concern for GMP industries. With a proven track record in managing highly technical and challenging isolation projects Dec is the perfect partner for the integration of new or existing equipment by providing comprehensive safe, ergonomic and dedicated containment solutions.
-
The Aseptic Filling Isolator is a custom-designed cGMP Class A/ISO 5 isolator system specifically designed for batch scale pharmaceutical production of injectable products for pre-clinical and clinical trial studies.
-
BPCs are single-use, flexible container systems commonly used for critical liquid-handling applications in the biopharmaceutical industry.